Trials / Unknown
UnknownNCT05250531
Multicomponent Therapy With Telerehabilitation
Efficacy of Telerehabilitation and Multicomponent Therapy in Women With Fibromyalgia: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Istanbul University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
In this prospective, randomized study, our aim was to evaluate the comprehensive multicomponent treatment of fibromyalgia women with telerehabilitation, including "patient education, special psychotherapy/psychosocial intervention, and exercise including relaxation exercises". Does it differ in terms of reduction and functionality?
Detailed description
Patients who meet the inclusion criteria will be randomized into two groups by computer program after being numbered according to the order of application. 33 patients in the multicomponent treatment group selected to group 1 (G1) will be treated with telerehabilitation for a total of 6 sessions of two hours once a week for 3 weeks. After 1 month, one more session will be applied for a two-hour follow-up and sustainability. As a control group, 33 patients selected to Group 2 (G2) will be given exercise and training with telerehabilitation. Patients to whom a multicomponent treatment program will be applied will be included in the program in groups of 10. The presentations will be prepared as power-point presentations and will be presented to the patients online with telerehabilitation. Interventions to be applied in the multicomponent treatment protocol: 1. Patient education 2. Exercise training 3. Private Psychotherapy 4. Relaxation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | multicomponent therapy | patient education,Exercise training,Private Psychotherapy,relaxation |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2022-02-22
- Last updated
- 2022-02-22
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05250531. Inclusion in this directory is not an endorsement.